Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 548

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 548
---
 thousands |   ​ | ​ | ​    
 2023 |     ​ | ​ 
 ​ 
 ​ |        ​ 
        ​ 
 % change 
        ​ | ​ 
 ​ |
|:-------------------|:--|:----------------------------|:--|:--|:-----|------:|:--|---------:|:--|:----------------------------|----:|:--|:-----|------:|:--|---------:|:--|
| Cost of Goods Sold | ​ | $                           | — | ​ | $    | 1,558 |   |     -100 | % | $                           | 620 | ​ | $    | 5,566 |   |      -89 | % |

There were no COGS recorded for the three months ended September 30, 2024 as there were no commercial sales during the period. Cara recorded COGS of $1.6 million for the three months ended September 30, 2023, and $0.6 million and $5.6 million for the nine months ended September 30, 2024 and 2023, respectively, which were related to Cara’s commercial supply revenue for KORSUVA injection sales to CSL Vifor for these periods.

298

Research and Development Expense

| ​                                                 
 ​                                                 
 ​                                                 
 ​                                                 
 ​                                                 | ​ 
 ​ 
 ​ | ​                           
 Three Months Ended          
 September 30,               
 2024                        
 Dollar amounts in thousands |     ​ | ​ | ​    
 2023 |      ​ | ​ 
 ​ 
 ​ |        ​ 
        ​ 
 % change 
        ​ | ​ 
 ​ 
 ​ | ​                           
 Nine Months Ended           
 September 30,               
 2024                        
 Dollar amounts in thousands |      ​ | ​ | ​    
 2023 |      ​ | ​ 
 ​ 
 ​ |        ​ 
        ​ 
 % change 
        ​ | ​ 
 ​ |
|:--------------------------------------------------|:--|:----------------------------|------:|:--|:-----|-------:|:--|---------:|:--|:----------------------------|-------:|:--|:-----|-------:|:--|---------:|:--|
| Direct clinical trial costs                       | ​ | $                           | 1,444 | ​ | $    | 16,210 |   |      -91 | % | $                           | 22,905 | ​ | $    | 50,496 |   |      -